RE: Activ Protocol V7 Released13 Oct 2021 20:02
Ndn, to me the difference here is key, noting the final few words in the June version:
From March:
1.3.14 Phase II: To determine whether SNG001 reduces severity of cough or shortness of
breath or difficulty breathing through study day 28
From June:
1.3.13 Phase II and III: To determine whether SNG001 reduces severity of shortness
of breath or difficulty breathing through study day 28.
1.3.14 Phase II and III: To determine whether SNG001 reduces a COVID-19 Severity Ranking scale based on COVID-19-associated symptom burden (severity and duration), hospitalization, and death, through study day 28 among individuals who report moderate to severe shortness of breath or difficulty breathing at day 0.